Ragon Institute of Mass General, MIT, and Harvard
Claire Brewer is the Director of IT at Ragon Institute of MGH, MIT and Harvard, with extensive experience in datacentre operations, finance, team management, and user engagement. Previous roles include Datacentre Team Leader at Imperial College London, Senior Systems Administrator/Datacentre Team Lead at The Francis Crick Institute, and Senior Systems Administrator at Cancer Research UK. Claire has also worked as a Systems Administrator at University of Sussex, Desktop Support Officer at University College London, and Database Administrator at London Borough of Enfield. Claire holds a BSc Hons in Computer Science from the University of Hertfordshire.
Ragon Institute of Mass General, MIT, and Harvard
1 followers
The Ragon Institute was established in 2009 with a dual mission: to contribute to the accelerated discovery of an HIV/AIDS vaccine and subsequently establish itself as a world leader in the collaborative study of immunology. Founded with a commitment of $100 million from Phillip T. (Terry) and Susan M. Ragon, and with an additional $200 million gift to endow the Institute announced on April 26, 2019, the Institute is structured and positioned to significantly contribute to a global effort to successfully develop an HIV/AIDS vaccine by: • Creating non-traditional partnerships among experts with different but complementary backgrounds; • Providing a means for rapidly funding promising studies; • Integrating key facets of vaccine development efforts that have tended to follow separate tracks; • Providing a substantial pool of accessible, flexible funding that lowers the threshold for scientists to pursue risky, unconventional avenues of study that are unlikely to attract funding from traditional sources. Such funding encourages innovation, compresses the time it takes to conduct bench-to-bedside research and attracts new minds to the field. The Ragon Institute creates a singular opportunity and environment to engage scientists, engineers and clinicians in challenging research for which there is no greater benefit – saving lives and curing the ill.